Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (6526)	5/10/1999 10:18:00 AM
From: Linda Kaplan	Respond to of 7041

I'm not going to rush to cover. As people integrate this news they will see there is no value in owning this stock. I think the stock will go to the low single digits this week. They will have to realize that entirely new trials still underway, mean that the drug won't be resubmitted to the FDA for a long time, if EVER! Then it will mean another year waiting about approval and that could eventuate in yet another non-approvable letter. I really don't think the hypesters will have credibility now. Some stockholders will hear about it when they get home from work tonight and will have to sell tomorrow. --Linda